Candidiasis in the Burned Patient
Overview
Authors
Affiliations
Candida organisms were cultured from 452 of 1,513 hospitalized burned patients during a 6-year study period. Of the 172 patients with colonization of the eschar by this fungus, only 20.7% subsequently developed invasive candidal sepsis. The mortality of untreated Candida burn wound infection was 100%, and with aggressive medical-surgical therapy, 91.6%. Candidemia was present in 52 patients and 76.9% of these died. Candida infection was seen as a preterminal phenomenon, coincident with a generalized collapse of patients' defensive and homeostatic mechanisms. For this reason, mortality was high and the infection rarely responded to treatment. Control of this lethal complication rests with prevention by the judicious use of intravenous broad-spectrum antibiotics and expeditious closure of the burn wound.
Van Bang B, Xuan N, Quang D, Loi C, Thai Ngoc Minh N, Lam N Curr Med Mycol. 2021; 6(3):42-49.
PMID: 33834142 PMC: 8018815. DOI: 10.18502/cmm.6.3.4664.
Church D, Elsayed S, Reid O, Winston B, Lindsay R Clin Microbiol Rev. 2006; 19(2):403-34.
PMID: 16614255 PMC: 1471990. DOI: 10.1128/CMR.19.2.403-434.2006.
Fluconazole pharmacokinetics in burn patients.
Boucher B, King S, Wandschneider H, Hickerson W, Hanes S, Herring V Antimicrob Agents Chemother. 1998; 42(4):930-3.
PMID: 9559811 PMC: 105570. DOI: 10.1128/AAC.42.4.930.
Robert F, Lebreton F, Bougnoux M, Paugam A, Wassermann D, SCHLOTTERER M J Clin Microbiol. 1995; 33(9):2366-71.
PMID: 7494029 PMC: 228413. DOI: 10.1128/jcm.33.9.2366-2371.1995.
The role of drugs in management of burns.
Pegg S Drugs. 1982; 24(3):256-60.
PMID: 7128481 DOI: 10.2165/00003495-198224030-00006.